Duffy A E, Asa S L, Kovacs K
University of Glasgow Medical School, UK.
Horm Res. 1988;30(1):32-8. doi: 10.1159/000181023.
The direct effect of short-term bromocriptine administration on human prolactin cell adenomas in vitro was studied by light and electron microscopy and correlated with the effect on hormone release. The light microscopic and, for the first time, ultrastructural characteristics of adenomatous prolactin cells in control and treated cultures were analyzed morphometrically and the changes induced by bromocriptine were quantified. Following 72 h treatment which lowered levels of prolactin release, there was a marked reduction in cell size, cytoplasmic volume and cytoplasmic volume densities of endoplasmic reticulum and Golgi apparatus. In contrast, the percentage of cytoplasm occupied by lysosomes increased. There was no consistent change in number and diameter of secretory granules. These findings indicate that prolactin cell involution is a direct effect of bromocriptine and suggest that reduction in endoplasmic reticulum and Golgi complex is largely responsible for the decreased cell size. Lysosomal degradation of cytoplasmic components may play a role in this process.
通过光学显微镜和电子显微镜研究了短期给予溴隐亭对人催乳素细胞腺瘤的直接作用,并将其与对激素释放的影响相关联。对对照培养物和经处理培养物中腺瘤性催乳素细胞的光学显微镜特征以及首次观察到的超微结构特征进行了形态计量分析,并对溴隐亭诱导的变化进行了量化。在进行72小时降低催乳素释放水平的治疗后,细胞大小、细胞质体积以及内质网和高尔基体的细胞质体积密度均显著降低。相比之下,溶酶体所占细胞质的百分比增加。分泌颗粒的数量和直径没有一致的变化。这些发现表明催乳素细胞退化是溴隐亭的直接作用,并提示内质网和高尔基体复合体的减少在很大程度上导致了细胞大小的减小。细胞质成分的溶酶体降解可能在此过程中起作用。